Direkt zum Inhalt
Merck
  • Effect of Relative Arrangement of Cationic and Lipophilic Moieties on Hemolytic and Antibacterial Activities of PEGylated Polyacrylates.

Effect of Relative Arrangement of Cationic and Lipophilic Moieties on Hemolytic and Antibacterial Activities of PEGylated Polyacrylates.

International journal of molecular sciences (2015-10-17)
Ashish Punia, Kevin Lee, Edward He, Sumit Mukherjee, Andrew Mancuso, Probal Banerjee, Nan-Loh Yang
ZUSAMMENFASSUNG

Synthetic amphiphilic polymers have been established as potentially efficient agents to combat widespread deadly infections involving antibiotic resistant superbugs. Incorporation of poly(ethylene glycol) (PEG) side chains into amphiphilic copolymers can reduce their hemolytic activity while maintaining high antibacterial activity. Our study found that the incorporation of PEG has substantially different effects on the hemolytic and antibacterial activities of copolymers depending on structural variations in the positions of cationic centers relative to hydrophobic groups. The PEG side chains dramatically reduced the hemolytic activities in copolymers with hydrophobic hexyl and cationic groups on the same repeating unit. However, in case of terpolymers with cationic and lipophilic groups placed on separate repeating units, the presence of PEG has significantly lower effect on hemolytic activities of these copolymers. PEGylated terpolymers displayed substantially lower activity against Staphylococcus aureus (S. aureus) than Escherichia coli (E. coli) suggesting the deterring effect of S. aureus' peptidoglycan cell wall against the penetration of PEGylated polymers. Time-kill studies confirmed the bactericidal activity of these copolymers and a 5 log reduction in E. coli colony forming units was observed within 2 h of polymer treatment.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Trifluoressigsäure, ReagentPlus®, 99%
Sigma-Aldrich
Ethylacetat, ACS reagent, ≥99.5%
Sigma-Aldrich
Diethylether, anhydrous, ACS reagent, ≥99.0%, contains BHT as inhibitor
Sigma-Aldrich
Dichlormethan, contains 40-150 ppm amylene as stabilizer, ACS reagent, ≥99.5%
Sigma-Aldrich
Tetrahydrofuran, contains 200-400 ppm BHT as inhibitor, ACS reagent, ≥99.0%
Sigma-Aldrich
Acetonitril, ACS reagent, ≥99.5%
Sigma-Aldrich
Tetrahydrofuran, anhydrous, ≥99.9%, inhibitor-free
Sigma-Aldrich
Hexan, ReagentPlus®, ≥99%
Sigma-Aldrich
Dichlormethan, anhydrous, ≥99.8%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
Tetrahydrofuran, anhydrous, contains 250 ppm BHT as inhibitor, ≥99.9%
Sigma-Aldrich
Diethylether, ACS reagent, anhydrous, ≥99.0%, contains BHT as inhibitor
Sigma-Aldrich
Acetonitril, anhydrous, 99.8%
Sigma-Aldrich
Trifluoressigsäure, puriss. p.a., suitable for HPLC, ≥99.0% (GC)
Sigma-Aldrich
N,N-Diisopropylethylamin, ReagentPlus®, ≥99%
Sigma-Aldrich
2,2′-Azobis(2-Methylpropionitril), 98%
Sigma-Aldrich
N,N-Diisopropylethylamin, 99.5%, biotech. grade
Sigma-Aldrich
Trifluoressigsäure, ≥99%, for protein sequencing
Sigma-Aldrich
Butylacrylat, ≥99%, contains 10-60 ppm monomethyl ether hydroquinone as inhibitor
Sigma-Aldrich
Dichlormethan, ACS reagent, ≥99.5%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
Hexan, Laboratory Reagent, ≥95%
Sigma-Aldrich
Ethylendiamintetraessigsäure Dinatriumsalz -Lösung, Molecular Biology, 0.5 M in H2O, DNase, RNase, NICKase and protease, none detected
Sigma-Aldrich
Acryloylchlorid, ≥97%, contains ~400 ppm phenothiazine as stabilizer
Sigma-Aldrich
Ethylacetat, anhydrous, 99.8%
Sigma-Aldrich
Diethylether, contains 1 ppm BHT as inhibitor, anhydrous, ≥99.7%
Sigma-Aldrich
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
N,N-Diisopropylethylamin, purified by redistillation, 99.5%
Sigma-Aldrich
Ethanolamin, ≥99%
Sigma-Aldrich
Di-tert-Butyldicarbonat, ReagentPlus®, 99%
Sigma-Aldrich
Ethanolamin, ≥98%
Sigma-Aldrich
Ethanolamin, purified by redistillation, ≥99.5%